Read as article
NSE Debuts on BSE After $2.4 Billion IPO, Enters Top 10
By @sharedot · · 8 pages
India's National Stock Exchange rose in its BSE debut after a $2.4 billion IPO, instantly ranking among the country's ten most valuable listed companies.
A Muted Open That Turned Into a Climb
National Stock Exchange of India shares listed at ₹1,800 on the Bombay Stock Exchange on Thursday, September 24, a premium of less than 1% over the ₹1,785 IPO price. The subdued start did not last: the stock climbed as much as 4.3% from the listing price to an intraday high of ₹1,878, up 5.2% from the issue price, according to Livemint. TradingView reported the pre-market print at ₹1,800, 0.8% above the offer price. The listing capped a road to public markets that began with a failed 2016 attempt stalled by regulatory and governance issues.
Why the Debut Is a First for India's Markets
The surprise is that one of India's most systemically important market operators, long blocked from going public, now trades on its chief rival's platform. The deal was an entirely an offer-for-sale of 12.64 crore shares, so NSE itself received no proceeds; the funds went to selling shareholders.
Institutions Bid Hard While Retail Stayed Cautious
The issue was subscribed 5.71 times overall, but demand was lopsided: qualified institutional buyers subscribed 12.68 times their allotment, non-institutional investors 6.55 times, and retail just 1.39 times, TronWeekly reports. Anchor and main-book participants included LIC, Norges Bank Investment Management, ICICI Prudential, Quant and Mirae Asset, plus Goldman Sachs Asset Management, HSBC, Fidelity, GIC, Abu Dhabi Investment Authority and Eastspring. Bloomberg Intelligence analyst Sharnie Wong wrote that earnings growth slowed in fiscal 2026 and will likely stay under pressure from regulatory scrutiny and higher taxes on futures and options trading.
Instantly Bigger Than HUL and Sun Pharma
At its debut, NSE's market capitalisation stood at ₹4.63 lakh crore, making it the tenth-largest listed Indian company — ahead of Hindustan Unilever at ₹4.53 lakh crore, Sun Pharmaceutical at ₹4.48 lakh crore and Titan at ₹4.43 lakh crore, Livemint reports. It now sits behind Reliance Industries (₹16.77 lakh crore) and HDFC Bank (₹11.25 lakh crore). By comparison, rival BSE's market capitalisation was ₹1.33 lakh crore, and NSE ranked as the world's eighth-largest listed exchange, per TradingView, versus LSEG's roughly $52.5 billion.
Derivatives Regulation Is the Key Risk
The big question hanging over the stock is revenue concentration: transaction fees from options accounted for more than 60% of operating revenue in fiscal 2026, and regulators have tightened rules to curb speculation in India's derivatives market. Livemint reports NSE's index-options market share has fallen to around 65% in YTD FY27 from dominance, with CAS and proprietary trading rules hitting volumes, while it still holds roughly 93% of the cash market. Analysts flag that additional share supply after six-month lock-ins expire could weigh on the price.
What Brokers Say Comes Next
Early brokerage coverage leans positive. Livemint reports Emkay initiated coverage with a Buy rating and a September 2027 target of ₹2,050, about 15% upside, citing India's capital-market financialisation runway; PL rated the stock Accumulate with a ₹1,950 target on 35x FY29E earnings, while ICICI Securities called NSE a play on the long-term growth of India's capital markets. Motilal Oswal chairman Raamdeo Agrawal, cited by TradingView, sees 15–20% annual growth potential over a decade, though regulatory headwinds could temper it near term. Attention now shifts to quarterly earnings, derivatives volumes and lock-in expiries.